Friday, September 29, 2017 10:15 PM ET
Insider at Emergent BioSolutions (EBS) Makes Significant Sale of Stock
One insider — Fuad El-Hibri, 10% Owner, Director and Officer — today, sold 50,000 shares of Emergent BioSolutions having a market value of approximately $2,000,000, as indicated in a form 4 document filed with the SEC. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 100,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 150,000 shares and have averaged 75,000 shares per transaction over this time period.
In relation to the peer group over the last 90 days, insider buy/sell trading at Emergent BioSolutions is above the 113-company peer group average. Pharmaceuticals peer group saw 113 buy/sell trades during this period for an average of 1.0 transactions per company. The number of shares per buy/sell trade for Emergent BioSolutions insiders was also higher. Within the peer group there were 3,194,503 shares purchased and 5,026,934 shares sold with company insiders having sold 16,216 shares on average.
Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in evaluating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.